Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice
2010

Metformin and its effects on aging in male mice

publication Evidence: moderate

Author Information

Author(s): Blagosklonny Mikhail V.

Primary Institution: Roswell Park Cancer Institute

Hypothesis

Does metformin have different effects on aging and lifespan in male and female mice?

Conclusion

Metformin may be harmful to young male mice by decreasing their lifespan despite its anti-aging properties.

Supporting Evidence

  • Metformin has been shown to slow aging in female mice but not in males.
  • Young male mice treated with metformin experienced a 13% decrease in lifespan.
  • Inhibition of the mTOR pathway by metformin may contribute to its anti-aging effects.

Takeaway

Metformin, a drug that helps with diabetes, might actually make young male mice live shorter lives, even though it can help other mice live longer.

Limitations

The study may not fully account for environmental factors affecting lifespan.

Participant Demographics

The study involved different strains of mice, focusing on gender differences.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication